4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-23-000126
Director sold 1,666 shares at $24.30 ($40,484)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SATO VICKI L Director | 2023-08-15 | Sale 10b5-1 | −1,666 | $24.30 | $40,484 | 131,371 | D: show line 1 in the form |
| Open-market sales · 1,666 sh · avg $24.30 · $40,484 | |||||||
Loading xslF345X05/wk-form4_1692312142.xml…